Correction: CD93 is expressed on chronic myeloid leukemia stem cells and identifies a quiescent population which persists after tyrosine kinase inhibitor therapy (Leukemia, (2020), 34, 6, (1613-1625), 10.1038/s41375-019-0684-5)

Ross Kinstrie; Gillian A. Horne; Heather Morrison; David Irvine; Chinmay Munje; Eduardo Gómez Castañeda; Hothri A. Moka; Karen Dunn; Jennifer E. Cassels; Narissa Parry; Cassie J. Clarke; Mary T. Scott; Richard E. Clark; Tessa L. Holyoake; Helen Wheadon; Mhairi Copland

ArticleOPEN ACCESS

Correction: CD93 is expressed on chronic myeloid leukemia stem cells and identifies a quiescent population which persists after tyrosine kinase inhibitor therapy (Leukemia, (2020), 34, 6, (1613-1625), 10.1038/s41375-019-0684-5)

Kinstrie R
Horne G
Morrison H
et al.

Leukemia

DOI: 10.1038/s41375-020-0721-4

0Citations

13Readers

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Cite

CITATION STYLE

APA

Kinstrie, R., Horne, G. A., Morrison, H., Irvine, D., Munje, C., Castañeda, E. G., … Copland, M. (2020, July 1). Correction: CD93 is expressed on chronic myeloid leukemia stem cells and identifies a quiescent population which persists after tyrosine kinase inhibitor therapy (Leukemia, (2020), 34, 6, (1613-1625), 10.1038/s41375-019-0684-5). Leukemia. Springer Nature. https://doi.org/10.1038/s41375-020-0721-4

Correction: CD93 is expressed on chronic myeloid leukemia stem cells and identifies a quiescent population which persists after tyrosine kinase inhibitor therapy (Leukemia, (2020), 34, 6, (1613-1625), 10.1038/s41375-019-0684-5)

Abstract

Cite

Register to see more suggestions